Get started
Author

Jonatan Nåtman

Observed names: J Natman, J NÅTMAN, J. Natman, J. Nåtman, JONATAN NÅTMAN, Jonatan Natman, MSc Jonatan Nåtman, Natman, Jonatan, Nåtman, Jonatan
Observed institutions: AstraZeneca (United Kingdom), Sahlgrenska University Hospital, Region Västra Götaland, Centre of Registers Vastra Gotaland, AstraZeneca (Sweden), The Swedish Hip Arthroplasty Register, AstraZeneca (United States)
ORCID: 0000-0001-6242-1810
Observed ORCIDs: 0000-0001-6242-1810, 0009-0002-1604-2435
OpenAlex ID: A5070524594
Effect of Diabetes on Morbidity and Mortality in Patients With Acromegaly
2022 · Daniela Esposito, Daniel S Olsson, et al. · The Journal of Clinical Endocrinology & Metabolism · 44
PDF
Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study
2022 · Ailiana Santosa, Stefan Franzén, et al. · Scientific Reports · 39
PDF
Trends in blood pressure, blood lipids, and smoking from 259 753 patients with hypertension in a Swedish primary care register: results from QregPV
2021 · Johan-Emil Bager, Georgios Mourtzinis, et al. · European Journal of Preventive Cardiology · 36
PDF
Total, hemi, or dual-mobility arthroplasty for the treatment of femoral neck fractures in patients with neurological disease
2021 · Peter H. J. Cnudde, Jonatan Nåtman, et al. · The Bone & Joint Journal · 32
The association of surgical approach and bearing size and type with dislocation in total hip arthroplasty for acute hip fracture
2022 · Cecilia Rogmark, Jonatan Nåtman, et al. · The Bone & Joint Journal · 24
A decade of improved glycemic control in young children with type 1 diabetes: A population‐based cohort study
2021 · Frida Sundberg, Jonatan Nåtman, et al. · Pediatric Diabetes · 24
PDF
The effect of statins on mortality and cardiovascular disease in primary care hypertensive patients without other cardiovascular disease or diabetes
2023 · Tobias Andersson, Jonatan Nåtman, et al. · European Journal of Preventive Cardiology · 20
PDF
Risk factors for reoperation due to periprosthetic joint infection after elective total hip arthroplasty: a study of 35,056 patients using linked data of the Swedish Hip Arthroplasty Registry (SHAR) and Swedish Perioperative Registry (SPOR)
2022 · Maria Qvistgaard, Jonatan Nåtman, et al. · BMC Musculoskeletal Disorders · 19
PDF
Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study
2022 · Jonas Brinck, Emil Hagström, et al. · Diabetes Care · 14
PDF
Total, hemi, or dual-mobility arthroplasty for the treatment of femoral neck fractures in patients with neurological disease : analysis of 9,638 patients from the Swedish Hip Arthroplasty Register.
2022 · Peter H J Cnudde, Jonatan Nåtman, et al. · PubMed · 13
Prior hip arthroscopy does not affect 1-year patient-reported outcomes following total hip arthroplasty: a register-based matched case-control study of 675 patients
2021 · Ida Lindman, Jonatan Nåtman, et al. · Acta Orthopaedica · 13
The different strategies in treating displaced femoral neck fractures: mid-term surgical outcome in a register-based cohort of 1,283 patients aged 60–69 years
2023 · Johan Lagergren, Sebastian Strøm Rönnquist, et al. · Acta Orthopaedica · 11
PDF
The True Dislocation Incidence following Elective Total Hip Replacement in Sweden: How Does It Relate to the Revision Rate?
2024 · Peter H. J. Cnudde, Jonatan Nåtman, et al. · Journal of Clinical Medicine · 10
PDF
Effect of a national infection control programme in Sweden on prosthetic joint infection incidence following primary total hip arthroplasty: a cohort study
2024 · Peter Wildeman, Ola Rolfson, et al. · BMJ Open · 9
PDF
Increased risk of hospitalization, intensive care and death due to COVID‐19 in patients with adrenal insufficiency: A Swedish nationwide study
2023 · Ragnhildur Bergthorsdottir, Daniela Esposito, et al. · Journal of Internal Medicine · 8
PDF
Long-term risk of reoperation after modular hemiarthroplasty
2023 · Dennis Lind, Jonatan Nåtman, et al. · BMC Musculoskeletal Disorders · 5
PDF
Initiation of antihypertensive drugs to patients with confirmed COVID‐19—A population‐based cohort study in Sweden
2022 · Salar Issa Mousa, Fredrik Nyberg, et al. · Basic & Clinical Pharmacology & Toxicology · 5
PDF
Long-term risk-factor control and secondary prevention are insufficient after first TIA: Results from QregPV
2023 · Johan-Emil Bager, Katarina Jood, et al. · European Stroke Journal · 4
The Prevalence of Joint Replacement in Sweden
2023 · O. Rolfson, J. Nåtman, et al. · Orthopaedic Proceedings · 3
Cardiovascular outcomes in patients with both diabetes and phenotypic familial hypercholesterolemia: a nationwide register-based cohort study
2022 · Associate Professor Jonas Brinck, Associate Professor Emil Hagström, et al. · 3
PDF
Hip arthroplasty for acute hip fracture in patients with neurological disorders: A report Of 9,702 cases from the Swedish arthroplasty register
2021 · Alex L. Wojtowicz, Waheeb Al-Azzani, et al. · Injury · 3
Neuropathy impairment and nutritional status with eplontersen in patients with hereditary transthyretin-mediated amyloidosis
2025 · Jonas Wixner, Isabel Conceição, et al. · Amyloid · 2
PDF
First year national Swedish paediatric Hba1c data are at the level of several intervention studies: Results from a Swedish nationwide diabetes register study
2024 · Isabelle I.K. Steineck, Johan Anderzén, et al. · Diabetes Research and Clinical Practice · 2
PDF
Improving cardiovascular control in a hypertensive population in primary care. Results from a staff training intervention
2024 · Rebecka Quester, Staffan Björck, et al. · Scandinavian Journal of Primary Health Care · 2
Dimensionality Reduction Techniques for Improving Propensity Score Specification: An Application to a Cohort Study Using Claims Data
2025 · Sudhir Venkatesan, Jonatan Nåtman, et al. · Pharmacoepidemiology and Drug Safety · 1
Works count: 65
Citation count: 379
H-index: 12
I10-index: 14
Year
Topic
Type